biotechnolgy

Biotech Scott Kirsner — Boston Globe

This billionaire has quietly driven Boston’s biotech industry for decades

Pharma Jessica Davis Plüss

European researchers seek greater stake in drug development in bid to improve access

Biotech Matthew Herper

Bristol Myers Squibb to buy Turning Point Therapeutics for $4.1 billion to gain drugs targeting rare cancer mutations

Biotech Matthew Herper and Megan Molteni

Bayer to pay CRISPR-focused Mammoth Biosciences $40 million for gene editing research

Politics Rachel Cohrs

The four senators who could make or break Democrats’ drug pricing ambitions